Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Preliminary Study

Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Preliminary Study

The in vitro study of sitafloxacin against carbapenem-resistant (CR) <i>Acinetobacter baumannii</i> demonstrated activity against most strains of CR <i>A. baumannii</i>, and the combination of colistin and sitafloxacin showed an in vitro synergistic effect against CR <i>...

Full description

Bibliographic Details
Main Authors: Rujipas Sirijatuphat, Supawas Thawornkaew, Darat Ruangkriengsin, Visanu Thamlikitkul
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Antibiotics
Subjects:
colistin
sitafloxacin
carbapenem-resistant
<i>Acinetobacter baumannii</i>
Online Access:https://www.mdpi.com/2079-6382/11/12/1707

Similar Items

Similar Items